• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - JUGULAR; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - JUGULAR; VENA CAVA FILTER Back to Search Results
Catalog Number RF320J
Device Problems Patient-Device Incompatibility (2682); Detachment of Device or Device Component (2907)
Patient Problem Abdominal Pain (1685)
Event Date 03/30/2018
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history record review could not be performed as the lot number is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately, two years and eleven months of post deployment, patient presented with the complaints of low back pain.An x-ray lumbar spine was performed which showed inferior vena cava filter was noted.Around, one year seventeen days later, an x-ray abdomen was performed which showed inferior vena cava filter was noted.After, eleven months and eight days, an x-ray gastrointestinal study was performed which showed inferior vena cava filter was noted at the level of l2.Around, four years and six months later, a computed tomography of abdomen and pelvis was performed which showed positive for filter fracture.A fracture of the 3 o¿clock stabilizing arm, 4 o¿clock fixation leg and 2 o¿clock fixation leg.Around, two months later, a computed tomography of abdomen and pelvis was performed for abdominal pain.The study showed that infrarenal inferior vena cava filter was noted.After, fourteen days, a computed tomography of abdomen and pelvis was performed for abdominal pain.The study showed that infrarenal inferior vena cava filter was noted.Therefore, the investigation is confirmed filter limb detachment.However, the investigation is inconclusive for perforation of the inferior vena cava (ivc).Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with trauma situation/motor vehicle accident.At some time post filter deployment, it was alleged that the filter perforated the inferior vena cava.The device has not been removed and there were no reported attempts made to retrieve the filter.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 FILTER SYSTEM - JUGULAR
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key12717483
MDR Text Key279024956
Report Number2020394-2021-80794
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K052578
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF320J
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/15/2021
Initial Date FDA Received10/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GABAPENTIN, METHOCARBAMOL, SIMVASTATIN AND ASPIRIN; HYDROCODONE-ACETAMINOPHEN AND DICLOFENAC; IBUPROFEN, FLUTICASONE, FAMOTIDINE AND LISINOPRIL
Patient Outcome(s) Other;
Patient Age64 YR
Patient Weight97
-
-